Outlook Therapeutics (OTLK) announced Faisal Sukhtian has been appointed as Chairman of the Board of Directors, effective immediately. Sukhtian will assume the role from Randy Thurman, who will remain on the Board as Lead Independent Director.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics announces presentation of data from NORSE EIGHT
- Outlook Therapeutics enters into agreement for warrant inducement transaction
- Outlook Therapeutics’ ONS-5010 shown to be non-inferior to Lucentis in wet AMD
- Biotech Alert: Searches spiking for these stocks today
- Outlook Therapeutics Faces Business Risks from Third-Party Manufacturing Dependencies